Bridging the Gap Between Parkinson’s Disease and Traumatic Brain Injury: The Role of Biological Assessments for Early Detection of Neurodegenerative Disease Risk and Prognosis of Clinical Outcomes
Year: 2024
Type: dissertation
Abstract: Parkinson’s Disease (PD) is currently the second most common neurodegenerative disease and concerningly, the most rapidly growing neurological disorder in the world. Once considered a hypokinetic motor disorder, it is now well-established that PD corresponds to various nonmotor impairments. While recent reforms of diagnostic guidelines have been made to reflect this, diagnosis still places heavy emphasis on motor presentation. This corresponds to various shortcomings, such as high rates of misdiagnosis, as well as relatively late diagnosis given that PD pathophysiology is known to develop several years prior to clinical onset, greatly diminishing efficacy of therapeutic interventions. Although, several strides have recently been made towards biologically redefining PD, offering an avenue for earlier and more effective diagnosis. This would heavily rely on earlier diagnosis requires identification of individuals within groups presenting high risk of future disease development, with one of research prominence being traumatic brain injury (TBI). As such, this thesis investigated the link between PD and TBI, particularly the utility of biological assessment for improved characterisation of outcomes in both neurological populations. Chapter 1 reviews literature outlining reform in PD diagnostic criteria, and how advancements in biological assessments could enable biological redefinition. Chapter 2 assesses the utility of biological assessment, such as biofluid biomarkers and neuroimaging, as well as comprehensive clinical assessment for prognosis in early PD. It was determined that of the predictors assessed, baseline concentrations of cerebrospinal fluid alpha synuclein and phosphorylated tau, as well as prodromal features such as hyposmia and autonomic dysfunction, significantly improved prognosis of more marked impairment well above clinical assessments currently utilised at time of diagnosis. Chapter 3 briefly outlines the importance of considering at-risk populations given the recent push towards biologically redefining PD for earlier diagnosis. Chapter 4 explored the influence TBI, as well as the potential moderating effects of injury severity, has on rate of progression of clinical and pathophysiological outcomes in two early PD cohorts. Chapters 5 and 6 assessed the potential prognostic utility of biological assessments in a TBI cohort. Given Chapter 2 identified biomarker concentrations collected acutely following diagnosis demonstrated prognostic utility up to several years, Chapter 5 employed a multilevel meta-analytic strategy to explore the associations between markers of cell injury collected within a week of injury with behavioural outcomes at any-time point following injury. It was found that regardless of moderators explored, biomarkers were significantly associated with global outcome following injury, however, literature assessing more specific outcomes such as cognition, mood and motor were much more limited. Chapter 6 explored the potential diagnostic of nigrosome-1 assessment using susceptibility weighted imaging across a TBI cohort, encompassing several injury severities and times since injury, relative to healthy controls and PD. Further, potential associations between nigrosome-1 voxel wise features and cognition across cohorts was explored. Overall, this thesis highlights that PD and TBI are complex disorders, reflected by large heterogeneity in the way they present clinically. Further, while the implementation of biological assessments acutely following diagnosis or time of injury for PD and TBI, respectively, shows promise for better characterisation of clinical course, further research must be conducted to determine how biological assessments correspond to more specific outcomes. Finally, this thesis brings attention to several gaps and limitations in current PD and TBI literature, advocating for further assessment of biomarkers in both cohorts to allow for earlier diagnosis and improved prognosis.
Author: McNamara, Angus
Institution: The University of Adelaide
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: Parkinson's disease, traumatic brain injury, early diagnosis, prodromal Parkinson's disease, alpha-synuclein, phosphorylated tau, cerebrospinal fluid biomarkers, hyposmia, autonomic dysfunction, injury severity, neurodegeneration, neuroinflammation, neuroprotection, neuroplasticity, neurobehavioral outcomes, prognostic factors
Open Access status: green
OpenAlex ID: W7217870248
